Browsing by Author "Cobankara, Veli"
Now showing items 1-6 of 6
-
Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study
Ozen, Gulsen; Inanc, Nevsun; Unal, Ali Ugur; Bas, Seda; Kimyon, Gezmis; Kisacik, Bunyamin; Onat, Ahmet Mesut; Murat, Sadiye; Keskin, Havva; Can, Meryem; Mengi, Alperen; Cakir, Necati; Balkarli, Ayse; Cobankara, Veli; Yilmaz, Neslihan; Yazici, Ayten; Dogru, Atalay; Sahin, Mehmet; Sahin, Ali; Gok, Kevser; Senel, Soner; Pamuk, Omer Nuri; Yilmaz, Sema; Bayindir, Ozun; Aksu, Kenan; Cagatay, Yonca; Akyol, Lutfi; Sayarlioglu, Mehmet; Yildirim-Cetin, Gozde; Yasar-Bilge, Sule; Yagci, Ilker; Aydin, Sibel Zehra; Alibaz-Oner, Fatma; Atagunduz, Pamir; Direskeneli, Haner (J RHEUMATOL PUBL CO, 2016)Objective. To assess the performance of the new 2012 provisional European League Against Rheumatism (EULAR)/ American College of Rheumatology (ACR) polymyalgia rheumatica (PMR) clinical classification criteria in discriminating ... -
Diagnostic dilemma of paraneoplastic arthritis: case series
Kisacik, Bunyamin; Onat, Ahmet M.; Kasifoglu, Timucin; Pehlivan, Yavuz; Pamuk, Omer N.; Dalkilic, Ediz; Donmez, Salim; Bilge, Sule Y.; Yilmaz, Sedat; Erdem, Hakan; Mercan, Ridvan; Ozturk, Mehmet A.; Bes, Cemal; Soy, Mehmet; Erten, Sukran; Cobankara, Veli; Senel, Soner; Oner, Fatma A.; Direskeneli, Haner; Yilmaz, Sema; Yazici, Ayten; Emmungil, Hakan; Aksu, Kenan; Kul, Seval; Cetin, Gozde Y.; Sayarlioglu, Mehmet (WILEY-BLACKWELL, 2014)Objectives: Paraneoplastic arthritis (PA) may mimic rheumatic diseases. While presenting the demographic and laboratory features of the patients diagnosed with PA, this study also aims to provide possible appropriate tools ... -
Effect of Infliximab Treatment on QT Intervals in Patients With Ankylosing Spondylitis
Senel, Soner; Cobankara, Veli; Taskoylu, Ozgur; Guclu, Aydin; Evrengul, Harun; Kaya, Mehmet Gungor (LIPPINCOTT WILLIAMS & WILKINS, 2011)Background: Cardiovascular complications are one of the most common and the most serious extraskeletal manifestations of ankylosing spondylitis (AS). Infliximab, a monoclonal antibody against tumor necrosis factor, is ... -
The efficacy and safety of etanercept in patients with rheumatoid arthritis and spondyloarthropathy on hemodialysis
Senel, Soner; Kisacik, Bunyamin; Ugan, Yunus; Kasifoglu, Timucin; Tunc, Ercan; Cobankara, Veli (SPRINGER LONDON LTD, 2011)We aimed to evaluate the efficacy and safety of long-term use of etanercept therapy in patients with spondyloarthropathy (SpA) and rheumatoid arthritis (RA) on hemodialysis (HD). Selected RA or SpA patients treated with ... -
The Safety and Efficacy of Etanercept on Cardiac Functions and Lipid Profile in Patients With Active Rheumatoid Arthritis
Senel, Soner; Cobankara, Veli; Taskoylu, Ozgur; Karasu, Ugur; Karapinar, Hekim; Erdis, Eda; Evrengul, Harun; Kaya, Mehmet Gungor (LIPPINCOTT WILLIAMS & WILKINS, 2012)Objectives: Patients with rheumatoid arthritis (RA) are known to be at increased cardiovascular risk. Etanercept is a tumor necrosis factor alpha (TNF-alpha) blocking agent that has been successfully used in the treatment ... -
Validation of New 2012 EULAR/ACR Classification Criteria for Polymyalgia Rheumatica: Comparison with the Previous Criteria in a Prospective Multi-Center Study
Ozen, Gulsen; Bas, Seda; Unal, Ali Ugur; Kimyon, Gezmis; Onat, Ahmet Mesut; Can, Meryem; Mengi, Alperen; Sahin, Ali; Yilmaz, Sema; Keskin, Havva; Murat, Sadiye; Balkarli, Ayse; Cobankara, Veli; Pamuk, Omer Nuri; Cagatay, Yonca; Yilmaz, Neslihan; Yagci, Ilker; Atagunduz, Pamir; Aydin, Sibel Z.; Inanc, Nevsun; Direskeneli, Haner (WILEY-BLACKWELL, 2014)…